Effects of the novel, selective and low-efficacy mu opioid receptor ligand NAQ on intracranial self-stimulation in rats (Q35027648)

5 August 2017

title

Effects of the novel, selective and low-efficacy mu opioid receptor ligand NAQ on intracranial self-stimulation in rats (English)

1 reference

5 August 2017

Ahmad A Altarifi

1

1 reference

5 August 2017

Yunyun Yuan

2

1 reference

5 August 2017

Yan Zhang

3

1 reference

5 August 2017

Dana E Selley

4

1 reference

5 August 2017

S Stevens Negus

5

1 reference

5 August 2017

publication date

3 September 2014

1 reference

5 August 2017

number of pages

10

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

5 August 2017

volume

232

1 reference

5 August 2017

issue

4

1 reference

5 August 2017

page(s)

815-824

1 reference

Intracranial self-stimulation to evaluate abuse potential of drugs.

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

NOP receptor mediates anti-analgesia induced by agonist-antagonist opioids

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Medications development for opioid abuse

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Role of µ-opioid receptor reserve and µ-agonist efficacy as determinants of the effects of µ-agonists on intracranial self-stimulation in rats

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as novel leads to development of mu opioid receptor selective antagonists

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Effects of the δ opioid receptor agonist SNC80 on pain-related depression of intracranial self-stimulation (ICSS) in rats

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Effects of peripherally restricted κ opioid receptor agonists on pain-related stimulation and depression of behavior in rats

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Some determinants of morphine effects on intracranial self-stimulation in rats: dose, pretreatment time, repeated treatment, and rate dependence

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

The selective non-peptidic delta opioid agonist SNC80 does not facilitate intracranial self-stimulation in rats

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Pharmacological Properties of Bivalent Ligands Containing Butorphan Linked to Nalbuphine, Naltrexone, and Naloxone at μ, δ, and κ Opioid Receptors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Pharmacotherapy of addictions

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptor.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Signal transduction correlates of mu opioid agonist intrinsic efficacy: receptor-stimulated [35S]GTP gamma S binding in mMOR-CHO cells and rat thalamus

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Addictive Drugs and Brain Stimulation Reward

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Normalized demand for drugs and other reinforcers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Review of self-administration

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Psychotomimesis mediated by kappa opiate receptors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Abuse liability studies of opioid agonist-antagonists in humans

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Opioid Agonist-Antagonist Drugs in Acute and Chronic Pain States

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Euphorigenic drugs: effects on the reward pathways of the brain

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Intracranial self-stimulation thresholds: a model for the hedonic effects of drugs of abuse

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

N-methylacetamide analog of salvinorin A: a highly potent and selective kappa-opioid receptor agonist with oral efficacy

8 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3719-7

Conditioned withdrawal drives heroin consumption and decreases reward sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3719-7

Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3719-7

Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3719-7

Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4310756

Nalbuphine Hydrochloride Dependence in Anabolic Steroid Users

25 October 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3719-7

Effects of heroin on lever pressing for intracranial self-stimulation, food and water in the rat

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25178814

12 December 2020

inferred from PubMed ID database lookup

The new mixed agonist-antagonist analgesics, nalbuphine and butorphanol, vs. pentazocine: relapse and substitution in morphine-addict rats

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25178814

12 December 2020

inferred from PubMed ID database lookup

Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25178814

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00213-014-3719-7

1 reference

5 August 2017

1 reference

5 August 2017

1 reference